Literature DB >> 11861051

Progestin implants for female contraception.

Horacio B Croxatt1.   

Abstract

Four different implants, in the form of capsules or covered rods, that release one of the synthetic progestins levonorgestrel, etonogestrel, Nestorone, or Elcometrine and nomegestrol acetate were reviewed. Biocompatible polymers or copolymers of polydimethyl/polymethylvinyl-siloxanes or ethylvinylacetate are used to hold the steroid crystals and to control the rate of release. Once inserted under the skin, these implants release the corresponding steroid continuously over prolonged periods, a process that can be readily interrupted by implant removal. During long-term use of the implant, the released steroid circulates in blood at a fairly stable level. The physical characteristics of the implants, including drug contents and rate of release, serum levels of the progestin during use, and the duration of their effective life are described. Total steroid loads vary in the range of 50 mg to 216 mg; average release rates are in the range of 30-100 ug/day, and effective lives from 6 months to 7 years.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861051     DOI: 10.1016/s0010-7824(01)00293-1

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Effect of crosslinking on the physicochemical properties of polydimethylsiloxane-based levonorgestrel intrauterine systems.

Authors:  Suraj Fanse; Quanying Bao; Yuan Zou; Yan Wang; Diane J Burgess
Journal:  Int J Pharm       Date:  2021-10-16       Impact factor: 6.510

Review 2.  Hormonal contraception in adolescents: special considerations.

Authors:  Rollyn M Ornstein; Martin M Fisher
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 3.  Recent progress in advanced biomaterials for long-acting reversible contraception.

Authors:  Mingzhe Yan; Yanming Zhang; Zhihang Wu; Yifei Li; Keke Dou; Banghui Wang; Yingruo Wang; Qihui Zhou
Journal:  J Nanobiotechnology       Date:  2022-03-17       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.